Drug interaction of tizanidine and fluvoxamine [4]

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 5, 2004, Pages 509-510

  Momo, Kenji ^a   Doki, Kosuke ^a   Hosono, Hiroyuki ^a   Homma, Masato ^b   Kohda, Yukinao ^b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; BEZAFIBRATE; CANDESARTAN; CARBAMAZEPINE; FAMOTIDINE; FLUNITRAZEPAM; FLUVOXAMINE; TICLOPIDINE; TIZANIDINE; ZOPICLONE;

AGED; AREA UNDER THE CURVE; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DEPRESSION; DIZZINESS; DROWSINESS; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; HYPOTHERMIA; KIDNEY FUNCTION TEST; LEG PAIN; LETTER; LIVER FUNCTION TEST; MUSCLE SPASM; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; SPEECH DISORDER;

ADRENERGIC ALPHA-AGONISTS; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY TEMPERATURE; CEREBRAL INFARCTION; CLONIDINE; DRUG INTERACTIONS; FEMALE; FLUVOXAMINE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 7944222698     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.08.003     Document Type: Letter

References (4)

1. I. Milanov, D. Georgiev Mechanisms of tizanidine action on spasticity Acta Neurol Scand 89 1994 274 279
2. M.T. Granfors, J.T. Backman, M. Neuvonen, J. Ahonen, P.J. Neuvonen Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction Clin Pharmacol Ther 75 2004 331 341
3. Interview form Ternelin. Available from: URL: http://www.novartis.co.jp/ product/ten/if/if_ten.pdf. Accessed June 10, 2004.
4. M. Nakajima, T. Yokoi, M. Mizutani, S. Shin, F.F. Kadlubar, T. Kamataki Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene Cancer Epidemiol Biomark Prev 3 1994 413 421